Elixinol Global Limited (OTC: ELLXF) Fast growing revenues in CBD & Hemp consumer products episode artwork

EPISODE · Dec 14, 2018 · 24 MIN

Elixinol Global Limited (OTC: ELLXF) Fast growing revenues in CBD & Hemp consumer products

from Wall Street Reporter

We caught up with Paul, at the airport, to discuss Elixinol’s progress in the CBD and hemp consumer products and foods markets, which has resulted in over AUD$14 million revenues and profits in Q2 2018.Paul also talks about the company’s business strategy, and the plans for deploying a recent AUD$40 million capital raise, to expand global sales growth. Hosted on Acast. See acast.com/privacy for more information.

Episode metadata supplied by the publisher feed · Published Dec 14, 2018

Embed this episode

NOW PLAYING

Elixinol Global Limited (OTC: ELLXF) Fast growing revenues in CBD & Hemp consumer products

0:00 24:23

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Wall Street Reporter?

This episode is 24 minutes long.

When was this Wall Street Reporter episode published?

This episode was published on December 14, 2018.

Can I download this Wall Street Reporter episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!